Development of a Stable Peptide-Major Histocompatibility Complex (MHC) via Sortase and Click Chemistry.
Journal
ACS pharmacology & translational science
ISSN: 2575-9108
Titre abrégé: ACS Pharmacol Transl Sci
Pays: United States
ID NLM: 101721411
Informations de publication
Date de publication:
14 Jun 2024
14 Jun 2024
Historique:
received:
03
10
2023
revised:
14
04
2024
accepted:
16
04
2024
pmc-release:
24
05
2025
medline:
20
6
2024
pubmed:
20
6
2024
entrez:
20
6
2024
Statut:
epublish
Résumé
T cells play a crucial role in antitumor immune responses and the clearance of infected cells. They identify their targets through the binding of T-cell receptors (TCRs) to peptide-major histocompatibility complex (pMHC) molecules present in cancer cells, infected cells, and antigen-presenting cells. This interaction is often weak, requiring multimeric pMHC molecules to enhance the avidity for identifying antigen-specific T cells. Current exchangeable pMHC-I tetramerization methods may overlook TCRs recognizing less stable yet immunogenic peptides.
Identifiants
pubmed: 38898944
doi: 10.1021/acsptsci.3c00268
pmc: PMC11184609
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1746-1757Informations de copyright
© 2024 American Chemical Society.
Déclaration de conflit d'intérêts
The authors declare no competing financial interest.